These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15480307)

  • 1. The role of activation-induced cytidine deaminase in antibody diversification, immunodeficiency, and B-cell malignancies.
    Luo Z; Ronai D; Scharff MD
    J Allergy Clin Immunol; 2004 Oct; 114(4):726-35; quiz 736. PubMed ID: 15480307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation.
    Basu U; Chaudhuri J; Alpert C; Dutt S; Ranganath S; Li G; Schrum JP; Manis JP; Alt FW
    Nature; 2005 Nov; 438(7067):508-11. PubMed ID: 16251902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2.
    Imai K; Zhu Y; Revy P; Morio T; Mizutani S; Fischer A; Nonoyama S; Durandy A
    Clin Immunol; 2005 Jun; 115(3):277-85. PubMed ID: 15893695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation-induced cytidine deaminase: a dual role in class-switch recombination and somatic hypermutation.
    Durandy A
    Eur J Immunol; 2003 Aug; 33(8):2069-73. PubMed ID: 12884279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defects of class-switch recombination.
    Notarangelo LD; Lanzi G; Peron S; Durandy A
    J Allergy Clin Immunol; 2006 Apr; 117(4):855-64. PubMed ID: 16630945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants.
    Durandy A; Peron S; Taubenheim N; Fischer A
    Hum Mutat; 2006 Dec; 27(12):1185-91. PubMed ID: 16964591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of immunoglobulin V-region diversification regulated by transcription and RNA metabolism in antigen-driven B cells.
    Sakaguchi N; Maeda K; Kuwahara K
    Scand J Immunol; 2011 Jun; 73(6):520-6. PubMed ID: 21388430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination.
    Imai K; Catalan N; Plebani A; Maródi L; Sanal O; Kumaki S; Nagendran V; Wood P; Glastre C; Sarrot-Reynauld F; Hermine O; Forveille M; Revy P; Fischer A; Durandy A
    J Clin Invest; 2003 Jul; 112(1):136-42. PubMed ID: 12840068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation-induced deaminase: light and dark sides.
    de Yébenes VG; Ramiro AR
    Trends Mol Med; 2006 Sep; 12(9):432-9. PubMed ID: 16861038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies.
    Durandy A; Taubenheim N; Peron S; Fischer A
    Adv Immunol; 2007; 94():275-306. PubMed ID: 17560278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for Msh6 but not Msh3 in somatic hypermutation and class switch recombination.
    Martomo SA; Yang WW; Gearhart PJ
    J Exp Med; 2004 Jul; 200(1):61-8. PubMed ID: 15238605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation-induced cytidine deaminase induces DNA break repair events more frequently in the Ig switch region than other sites in the mammalian genome.
    Lee SA; Parsa JY; Martin A; Baker MD
    Eur J Immunol; 2007 Dec; 37(12):3529-39. PubMed ID: 18034427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences.
    Dudley DD; Chaudhuri J; Bassing CH; Alt FW
    Adv Immunol; 2005; 86():43-112. PubMed ID: 15705419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil.
    Kavli B; Andersen S; Otterlei M; Liabakk NB; Imai K; Fischer A; Durandy A; Krokan HE; Slupphaug G
    J Exp Med; 2005 Jun; 201(12):2011-21. PubMed ID: 15967827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of AID-mediated sequence diversification by cis-acting determinants.
    Yang SY; Schatz DG
    Adv Immunol; 2007; 94():109-25. PubMed ID: 17560273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic events triggered by AID, the adverse effect of antibody diversification.
    Pérez-Durán P; de Yebenes VG; Ramiro AR
    Carcinogenesis; 2007 Dec; 28(12):2427-33. PubMed ID: 17804422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination.
    Hackney JA; Misaghi S; Senger K; Garris C; Sun Y; Lorenzo MN; Zarrin AA
    Adv Immunol; 2009; 101():163-89. PubMed ID: 19231595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human splenic marginal zone B cells lack expression of activation-induced cytidine deaminase.
    Willenbrock K; Jungnickel B; Hansmann ML; Küppers R
    Eur J Immunol; 2005 Oct; 35(10):3002-7. PubMed ID: 16180254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects.
    Durandy A; Revy P; Imai K; Fischer A
    Immunol Rev; 2005 Feb; 203():67-79. PubMed ID: 15661022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation.
    Smit LA; van Maldegem F; Langerak AW; van der Schoot CE; de Wit MJ; Bea S; Campo E; Bende RJ; van Noesel CJ
    Haematologica; 2006 Jul; 91(7):903-11. PubMed ID: 16818277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.